Thursday, January 23, 2014

The Motley Fool: Wall Street Less Forgiving Toward Abbott Laboratories This Time

With stocks like St. Jude Medical, Boston Scientific, Medtronic (NYSE: MDT  ) , and Johnson & Johnson (NYSE: JNJ  ) so strong in 2013, Abbott Labs (NYSE: ABT  ) has been tapped by many sell-side analysts as a catch-up pick for 2014. For the second straight quarter, though, Abbott has come in a little shy of growth expectations. Although the excuse was reasonable (the ongoing impact of Fonterra recalls on nutrition), there's not a lot of tolerance in Abbott's valuation model for ongoing shortfalls.

Please read more here:
Wall Street Less Forgiving Toward Abbott Laboratories This Time

No comments: